Our data show that pan PPAR-iMSC-EVs ameliorated the progression of NASH as shown by the gross morphology and histological analysis of liver tissue, serum liver function markers, NAS score, and the reduced lipid droplet deposition in the liver of NASH mice. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatohepatitis.